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Abstract: Background: Radiation-induced heart injury can lead to increased risk of heart failure, attack,
and ischemia. Some studies proposed IL-4 and IL-13 as two important cytokines that are involved
in late effects of ionizing radiation. On the other hand, these cytokines may, through upregulation
of Duox1 and Duox2, induce chronic oxidative stress, inflammation, and fibrosis. In this study, we
evaluated the upregulation of Duox1 and Duox2 pathways in hearts following chest irradiation in rats
and then detected possible attenuation of them by melatonin. Materials and Methods: Twenty male
Wistar rats were divided into four groups: (1) control; (2) melatonin treated (100 mg/kg); (3) radiation
(15 Gy gamma rays); (4) melatonin treated before irradiation. All rats were sacrificed after 10 weeks
and their heart tissues collected for real-time PCR (RT-PCR), ELISA detection of IL-4 and IL-13, as well
as histopathological evaluation of macrophages and lymphocytes infiltration. Results: Results showed
an upregulation of IL-4, IL4ra1, Duox1, and Duox2. The biggest changes were for IL4ra1 and Duox1.
Treatment with melatonin before irradiation could attenuate the upregulation of all genes. Melatonin
also caused a reduction in IL-4 as well as reverse infiltration of inflammatory cells. Conclusion: Duox1
and Duox2 may be involved in the late effects of radiation-induced heart injury. Also, via attenuation
of these genes, melatonin can offer protection against the toxic effects of radiation on the heart.
Keywords: radiation; melatonin; IL-4; Duox1; Duox2; heart
1. Introduction
Heart tissue is one of the late responding tissues to ionizing radiation. Cardiovascular diseases
are among the common non-cancerous disorders for people who have been exposed to ionizing
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radiation [1]. The most obvious examples of radiation-induced heart diseases include increased risk
of heart failure, attack, and ischemia among Chernobyl, Hiroshima, and Nagasaki survivors [2,3].
Increased risk of cardiovascular diseases has been observed in lung and left breast cancer patients [4].
Some radiobiological studies have reported that damages to other organs such as the respiratory
system or kidneys may lead to changes in normal physiological functions of the heart and induce heart
damage markers [5]. Studies have reported that pathological heart changes may take months to years
after exposure to ionizing radiation to appear. In addition, the incidence of heart injury has a direct
relationship with radiation dose [6].
Although the exact mechanisms of radiation-induced cardiovascular injury have not been
completely defined, reports show that infiltration of inflammatory cells plays a key role in chronic
oxidative stress, collagen deposition, and changes in the normal structure of heart tissue. Macrophages
and lymphocytes are common inflammatory cells following exposure to ionizing radiation. Emerging
evidence has also proposed a key role for mast cells [7]. Inflammatory cells induce the release
of several cytokines, such as IL-1, IL-2, IL-4, IL-6, IL-8, IL-13, TNF-α, and TGF-β, which mediate
continuous reactive oxygen species (ROS) and nitric oxide (NO) production through reduction/oxidation
reactions [8]. However, the regulation of these cytokines and downstream genes may be tissue
dependent. Chronic oxidative stress and inflammation lead to fibrosis and hypertrophy, which may
disrupt normal heart function and blood supply to the heart muscle [9].
Recent studies have proposed that IL-4 and IL-13 through upregulation of Duox1 and Duox2
induce chronic oxidative stress and fibrosis [10]. The main receptors for IL-4 and IL-13 are IL4ra1 and
IL13ra2. In addition to Duox1 and Duox2, IL-4 induces upregulation of TGF-β, a potent stimulator of
pro-oxidant enzymes and fibrosis [11]. In the current study, we aimed to evaluate the upregulation of
two pro-oxidant genes, Duox2 and Duox1, following irradiation of the heart tissue of rats.
A previous study by Hassani et al. showed that upregulation of these pathways, especially a
long-term increase in Duox1, leads to continuous ROS production and genomic instability in thyroid
carcinoma cells [10]. This may indicate that in addition to pathological damage to irradiated organs, the
increased level of IL-4 or IL-13 and downstream genes trigger genomic instability and carcinogenesis.
Duox1 and Duox2 are two membrane-dependent subfamilies of oxidoreductase enzymes that catalyze
conversion of oxygen (O2) to hydrogen peroxidase (H2O2) [12]. These two enzymes are very similar
and are able to generate a large amount of H2O2 following activation [12]. Abnormal upregulation of
these enzymes may lead to the disruption of normal functions of cells and also an increase in oxidative
injury [13].
Some natural or chemical agents have been used to reduce radiation-induced heart injury [14,15].
Melatonin is a natural, low toxic hormone that has shown potent radioprotective effects. One of the
main effects of melatonin against radiation-induced toxicity is its potent antioxidant defense. It can
directly or indirectly neutralize ROS and NO produced by ionizing radiation and pro-oxidant enzymes.
The indirect effect of melatonin is mediated via stimulation of the antioxidant defense, including
glutathione (GSH), glutathione peroxidase (GPx), superoxidase dismutase (SOD), glutathione reductase
(GR), and catalase (CAT) [16]. Melatonin has also shown the ability to suppress chronic inflammation
and oxidative stress following exposure to ionizing radiation [17]. The enhancement of the DNA
damage response by melatonin has been suggested to prevent triggering of inflammatory reactions
following exposure to radiation [18]. Melatonin can also suppress overexpression of pro-oxidant
enzymes such as cyclooxygenase-2 (COX-2), nicotinamide adenine dinucleotide phosphate (NADPH)
oxidase, and inducible nitric oxide synthase (iNOS) [19]. These are associated with reduced release of
pro-inflammatory and pro-fibrosis cytokines [19]. Interestingly, it has been reported that melatonin
may induce different effects such as depletion of GSH and induction of cell death in some cancer
cells [20]. The differential effects of melatonin on healthy and cancerous cells make it a potential
candidate for use as an adjuvant in radiotherapy [18].
In the present study, melatonin was used to reduce radiation-induced heart injury. In addition,
the modulation of IL-4 and IL-13 signaling pathways were also detected.
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2. Materials and Methods
2.1. Experimental Design
Melatonin was obtained (Merck company, Darmstadt, Germany) and dissolved in 20% ethanol.
For melatonin administration, 1 cc of this solution (100 mg/kg) was injected to each rat intraperitoneally.
In this study, 20 adult Wistar male rats (200 ± 20 g) were purchased from Razi Institute, Tehran
University of Medical Sciences, Tehran, Iran. All animals were housed in suitable conditions, which
included the following: temperature (23 ± 2 ◦C), humidity (55%) and the same light/dark cycles
(light 08:00 to 20:00 and dark 20:00 to 08:00) to prevent any effect of light/dark on basal levels of
melatonin. The rats were randomized into four groups (5 rats in each) as follows: group 1: control;
group 2: melatonin treated; group 3: radiation; group 4: melatonin treated + radiation. Melatonin was
administered 30 minutes before irradiation. A 60Co gamma ray source was used to deliver 15 Gy to the
heart. Ten weeks after irradiation, all rats were sacrificed to extract their heart tissues. Ventricles were
fixed in 10% formalin while their auricles were frozen for real-time PCR.
2.2. Real-Time PCR
Total mRNA was isolated from frozen heart tissues of all groups using a TRIzol reagent (Sinagene,
Tehran, Iran) while cDNA templates were synthesized using a cDNA synthesis kit (Geneall, Seoul,
South Korea) according to the manufacturer’s instructions. The expressions were performed using
Corbett real-time PCR (USA). Primers were designed using Generunner software (Hastings Software.
Inc. Hastings, NY, USA) and NCBI BLAST. The forward and reverse sequences of primers are shown
in Table 1.
Table 1. Forward and reverse sequences of primers.
Gene Forward Sequence Reverse Sequence
IL-4r1 GAGTGAGTGGAGTCCCAGCATC GCTGAAGTAACAGGTCAGGC
Duox1 AAGAAAGGAAGCATCAACACCC ACCAGGGCAGTCAGGAAGAT
Duox2 AGTCTCATTCCTCACCCGGA GTAACACACACGATGTGGCG
PGM1 CATGATTCTGGGCAAGCACG GCCAGTTGGGGTCTCATACAAA
2.3. ELISA
The levels of both cytokines IL-4 and IL-13 were detected using an ELISA kit (Zellbio, Krantorweg,
Berlin, Germany) according to manufacturer’s instructions.
2.4. Pathological Study
Fixed heart tissues were embedded in paraffin blocks and then sliced into 5 µm sections. Slides
were stained using hematoxylin and eosin (H&E) for evaluating infiltration of macrophages and
lymphocytes. Histopathological assessments were carried out with the aid of a light microscope.
2.5. Statistical Analysis
All statistical analyses were conducted using SPSS software version 16 (SPSS, Inc, Chicago, IL,
USA). The significance of the mean ± standard deviations for ELISA and histopathological evaluations
were analyzed using the ANOVA test with post hoc Tukey’s HSD, while real-time PCR results were
analyzed using the T-test. The p values < 0.05 were considered statistically significant.
2.6. Ethical Approval
This study was approved by ethical committee of Kashan University of Medical Sciences, Kashan,
Iran, with ethical code IR.KAUMS.NUHEPM.REC.1397.006, Approval Date: 2018-05-07.
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3. Results
3.1. Real-Time PCR
Results of the real-time PCR showed a significant increase in the expression of IL4ra1 compared to
the control group (28 ± 8.20) (p < 0.05). Melatonin administration before exposure to ionizing radiation
led to a significant reduction in IL4ra1 compared to the control group (9.2 ± 2.15) (p < 0.05). Irradiation
of heart tissues caused a significant increase in the expression of Duox1 (20.3 ± 4.6) (p < 0.05). When rats
were treated with melatonin, the expression of Duox1 was significantly attenuated (9.8 ± 3.4) (p < 0.05).
Irradiation of rats’ heart tissues also caused a significant increase in Duox2 gene expression (8.35 ± 2.8)
(p < 0.05). Melatonin administration attenuated its expression (3.22 ± 0.55) compared to the radiation
group (p < 0.05) (Figure 1).
Figure 1. The expression of IL4ra1, Duox1, and Duox2 in rats’ heart following melatonin treatment,
irradiation, and melatonin treatment before irradiation. The expressions of genes were normalized
compared to PGM1 as an internal control. a: significant compared to control group; b: significant
compared to radiation group, (T-test, p < 0.05).
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3.2. ELISA
IL-4 and IL-13 are low half-life cytokines of 19 min and 1.4 hour, respectively [21,22]. However,
they may vary for various species. ELISA assay results showed that irradiation of rats’ heart tissues
caused a significant increase in the level of IL-4 (739 ± 42 pg/mL) compared to the control group
(414 ± 57 pg/mL) (p < 0.01). Treatment with melatonin before irradiation led to a significant decrease
in IL-4 contents of cells (522 ± 26 pg/mL) (p < 0.01). Treatment with melatonin alone did not induce
any significant change. In the case of IL-13, no significant change was observed for any of the groups
(Figure 2).
Figure 2. The levels of IL-4 (a) and IL-13 (b) in control, melatonin (MLT), radiation (RAD), and radiation
+ melatonin (RAD+MLT) groups. Results show an increase in IL-4 following irradiation of rats’ heart
tissues. However, IL-4 decreased when melatonin was administered before irradiation. Results show
no significant change in IL-13 for all groups; a: significant compared to control group; b; significant
compared to radiation group, (ANOVA, Tukey’s HSD, p < 0.05).
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3.3. Histopathological Evaluation
Histopathological study showed a mild infiltration of macrophages and lymphocytes following
irradiation of rats’ heart tissues. This was more obvious for lymphocytes. However, when rats were
treated with melatonin before irradiation, results showed no infiltration of these cells in heart tissues
(Figure 3).
Figure 3. Irradiation of the hearts of rats caused a mild infiltration of inflammatory cells, especially
lymphocytes. In the melatonin + radiation group, there was no sign of infiltration of inflammatory
cells. (A) control; (B) melatonin treated; (C) radiation; (D) melatonin + radiation (hematoxylin and
eosin (H&E) staining).
4. Discussion
In the current study, we evaluated the upregulation of two important ROS producing agents
(Duox1 and Duox2) following heart irradiation. These genes are affected by immune system mediators,
especially IL-4 and IL-13. As IL-13 and IL-4 are two important pro-fibrotic cytokines, we hypothesized
that chronic upregulation of these cytokines may be associated with increased upregulation of Duox1
and Duox2. It has also been confirmed that IL-4 causes maintenance of macrophages in irradiated
tissues. These changes can stimulate redox reactions, leading to chronic oxidative stress, inflammation,
and damage to normal heart function. We observed that irradiation of rats’ heart tissues led to
increased levels of IL-4 but not IL-13. Real-time PCR showed that irradiation caused significant
upregulation of IL4ra1, Duox1, and Duox2. These changes were obvious for IL4ra1 and Duox1. In
addition, histopathological evaluation showed infiltration of lymphocytes and macrophages following
exposure to radiation.
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Suppression of inflammatory and pro-fibrotic cytokines have been studied for amelioration of
radiation injury in irradiated tissues [23,24]. Inhibition of IL-4 has been shown to alleviate radiation
injury, especially infiltration of macrophages in the lung [25]. In addition, inhibition of Duox1 can
attenuate chronic oxidative stress, genomic instability, and late effects of exposure to radiation [10].
In the current study, we used melatonin to attenuate upregulation of IL4ra1, Duox1, and Duox2
following irradiation of rats’ heart tissues. Results showed that treatment with melatonin before
irradiation reduces upregulation of these genes. Melatonin can also attenuate increased levels of IL-4
and infiltration of lymphocytes and macrophages.
Melatonin, which was used as a radioprotector in the present study, is an interesting agent for
use as a low-toxic adjuvant for patients that undergo radiotherapy. Melatonin can be proposed as an
appropriate radioprotector for early and late effects of ionizing radiation in various organs. It is able to
attenuate increased level of inflammatory and pro-fibrotic cytokines following exposure to radiation or
chemotherapy agents. These effects result from the reduction of upregulation of transcription factors
including signal transducer and activator of transcriptions (STATs) and nuclear factor-κB (NF-κB) [26].
Melatonin is able to blunt translocation of NF-kB into the nucleus, thus preventing upregulation
of COX-2, NADPH oxidase subfamilies (NOX2 and NOX4), and iNOS [27]. Via protection of the
mitochondria against radiation-induced mitochondrial DNA (mtDNA) injury, melatonin prevents
increased inflammasomes and further secretion of IL-1 and IL-18 [28]. Melatonin can attenuate the
activity of macrophages [29]. As macrophage activity plays a key role in the release of pro-fibrotic
cytokines such as TGF-β, IL-4, IL-10, and IL-13, melatonin may have a beneficial effect in the prevention
of the late effects of ionizing radiation through modulation and maintenance of macrophages [30].
Apoptosis and senescence are important types of cell death following exposure to radiation that may be
involved in the infiltration of macrophages to irradiated tissues [31]. Melatonin has shown the ability
to attenuate radiation-induced apoptosis and senescence [32]. Preventing macrophage infiltration by
melatonin, as observed in the current study, may be involved in the suppression of IL-4 and also other
downstream genes including IL4ra1, Duox1, and Duox2.
In recent years, some studies have been conducted to alleviate radiation toxicity in heart tissue.
Amifostine, a food and drug administration (FDA) approved radioprotector, has shown some protective
effects in rat’s heart tissues. However, it protects heart tissues only against some adverse effects, but
not all of them [33]. In addition, some clinical studies have shown that treatment with amifostine
may lead to severe toxicity in patients, hence a discontinuation of treatment [34]. Therefore, treatment
with natural radioprotectors may be more effective due to their low toxicities and minimal side effects.
In a previous study, we showed that hesperidin as a natural antioxidant has the ability to reduce
radiation-induced heart injury. We also showed that the most obvious effect of hesperidin is related to
preventing infiltration of macrophages in rat’s heart tissues [35]. In this study, we report for the first
time the ability of melatonin to inhibit Duox1 and Duox2 in rat’s heart tissues. This may be proposed as
a mechanism for radioprotection by melatonin.
5. Conclusions
This study has shown that irradiation of the hearts of rats leads to activation of IL-4 and its
downstream genes: IL4ra1, Duox1, and Duox2. In addition, the expression of Duox1 was increased
without upregulation of IL-13, which may indicate a role of other mediators such as IL-4 in the
expression of Duox1. Treatment with melatonin before irradiation could attenuate upregulation of IL-4,
IL4ra1, Duox1, and Duox2. It also reversed the infiltration of inflammatory cells, including macrophages
and lymphocytes. It is possible that melatonin via suppression of IL-4 and pro-oxidant enzymes
including Duox1 and Duox2 protects against ionizing radiation-induced heart injury. As the release of
IL-4 is highly dependent on the activity of macrophages, there is a possibility that melatonin reduces
chronic inflammation via preventing macrophage infiltration and oxidative stress. As infiltration of
macrophages is highly dependent on the induction of apoptosis and senescence following exposure to
Medicina 2019, 55, 317 8 of 10
radiation, pre-irradiation administration of melatonin may reduce chronic infiltration of macrophages
via the reduction of cell death.
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